Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us

    News: Faculty Staff News

    Cancer groups call for regulation of e-cigarettes

    Thursday, January 15th, 2015

    Two leading cancer organizations are calling for regulation of e-cigarettes and other electronic nicotine delivery systems (ENDS). The American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) issued the joint statement calling for greater oversight of the products and more research about their effects on the long-term health of users. […]

    Tindle to lead Tobacco Research and Treatment

    Friday, November 21st, 2014

    November is well-known as Lung Cancer Awareness Month. It is also the month that highlights awareness of less publicized forms of cancer including pancreatic cancer and stomach cancer. All three of these diseases share a common risk factor — cigarette smoking. “Smoking is the leading cause of preventable disease and death and it is claiming […]

    VICC Investigators Earn Breast Cancer Grants

    Thursday, October 23rd, 2014

    Three Vanderbilt-Ingram Cancer Center (VICC) investigators have been awarded breast cancer research grants totaling $830,000 from the Susan G. Komen organization.

    Penson to Lead Urologic Surgery

    Thursday, September 11th, 2014

    David Penson, M.D., will become chair of Vanderbilt’s Department of Urologic Surgery, effective Jan. 1, 2015.

    Engelhardt Lands Stem Cell Transplant Grant

    Thursday, September 11th, 2014

    Brian Engelhardt, M.D., MSCI, assistant professor of Medicine, has received a Mentored Career Development Award from the National Heart, Lung, and Blood Institute, a division of the National Institutes of Health, to explore the causes of post-transplant diabetes development.

    Study identifies genes tied to colon cancer

    Friday, August 22nd, 2014

    by Dagny Stuart Colorectal cancer is one of the leading causes of death among populations around the world. While diet, physical activity and other lifestyle factors can influence the risk of developing the disease, hereditary factors also play an important role. Genetic factors identified to date explain only a small fraction of colorectal cancer (CRC), […]

    Colon cancer’s protein signatures identified

    Friday, July 25th, 2014

    by Bill Snyder A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer. The technological tour de force, described as the first integrated “proteogenomic” characterization of human cancer, was reported online this week by the journal Nature. It […]

    Abramson lands breast cancer research award

    Wednesday, July 23rd, 2014

    by Dagny Stuart     Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF). The CCF grants and awards support cancer research done by physician-scientists at every stage of their careers. Abramson’s […]

    Research bolstered by lung cancer foundation

    Monday, July 21st, 2014

    by Dagny Stuart The LUNGevity Foundation has awarded a 2014 Career Development Award for Translational Research to Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology. Lovly is one of three recipients of the annual grants, which provide $300,000 over three years for lung cancer research. “This is a wonderful award and I […]

    VICC researchers in national spotlight

    Wednesday, June 25th, 2014

    by Dagny Stuart Early research suggests patients with advanced melanoma — the most deadly form of skin cancer — may benefit from both immunotherapies and targeted therapies aimed at specific gene mutations. However, no combinations of these two classes of drugs have been shown to be safe, so far. The results of the first such […]

    Next Page »« Previous Page